International Medical Case Reports Journal · 2014 · 15 citations · 9 references
MedicineHematologyPharmacotherapyClinical PharmacologyHemostasisVascular SurgeryAnticoagulant TherapyAnticoagulation TherapyDeep Vein ThrombosisThromboembolic DiseaseThrombosisVenous ThromboembolismDeep Vein Thrombosis ProphylaxisFibrin Clot FormationLow-molecular-weight Heparin TherapySystemic AnticoagulationWarfarin Dose Optimization
Abstract: We are presenting a 72-year-old female who was admitted to hospital with deep vein thrombosis (DVT). She was known to have atrial fibrillation and was initiated on warfarin for stroke prophylaxis 3 days earlier. She was given warfarin therapy without low molecular weight heparin cover as per “slow-start regimen” protocol. The warfarin dose was increased after 3 days to achieve rapid anticoagulation, resulting in DVT in the left leg. We propose that the higher unopposed warfarin dose utilized in this case resulted in DVT. Warfarin loading doses may paradoxically result in a hypercoagulable state and potential clot formation because of significant reductions in protein C and protein S levels. Keywords: warfarin, deep vein thrombosis, slow-start regimen, protein C, protein S, warfarin-induced skin necrosis, stroke prophylaxis
9
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Antithrombotic Therapy for VTE Disease
Clive Kearon, Elie A. Akl, Anthony J. Comerota et al. · CHEST Journal · 2012 · 6.1K citations · Full text
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Valentı́n Fuster, Lars Rydén, David S. Cannom et al. · Circulation · 2006 · 2.8K citations · Full text
Gordon Guyatt, Elie A. Akl, Mark Crowther et al. · CHEST Journal · 2012 · 1.5K citations · Full text
Valentı́n Fuster, Lars Rydén, Richard Asinger et al. · European Heart Journal · 2001 · 493 citations · Full text